About the Authors

Patrick N. Harter

Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

Jenny Zinke

Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany

Alexander Scholz

Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany

Julia Tichy

Affiliation Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany

Cornelia Zachskorn

Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

Hans M. Kvasnicka

Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Senckenberg Institute of Pathology, University of Frankfurt am Main, Frankfurt am Main, Germany

Benjamin Goeppert

Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Institute of Pathology, University of Heidelberg, Heidelberg, Germany

Céline Delloye-Bourgeois

Affiliation Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France

Elke Hattingen

Affiliation Institute of Neuroradiology, University of Frankfurt am Main, Frankfurt am Main, Germany

Christian Senft

Affiliation Department of Neurosurgery, University of Frankfurt am Main, Frankfurt am Main, Germany

Joachim P. Steinbach

Affiliations German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany, Senckenberg Institute of Neurooncology, University of Frankfurt am Main, Frankfurt am Main, Germany

Karl H. Plate

Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

Patrick Mehlen

Affiliation Apoptosis, Cancer and Development Laboratory, Equipe labellisée ‘La Ligue’, LabEx DEVweCAN, Centre de Cancérologie de Lyon, INSERM U1052-CNRS UMR5286, Université de Lyon, Centre Léon Bérard, Lyon, France

Dorothea Schulte

Affiliation Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany

Michel Mittelbronn

michel.mittelbronn@kgu.de

Affiliations Edinger Institute, Institute of Neurology, University of Frankfurt am Main, Frankfurt am Main, Germany, German Cancer Consortium (DKTK), Heidelberg, Germany, German Cancer Research Center (DKFZ), Heidelberg, Germany

Competing Interests

The authors have read the journal’s policy and have the following conflicts: Patrick Mehlen declares to have a conflict of interest as founder and shareholder of Netris Pharma. However, this does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials.

Author Contributions

Conceived and designed the experiments: PNH AS HMK BG CDB EH PM DS MM. Performed the experiments: PNH JZ AS JT CZ CDB EH DS. Analyzed the data: PNH JZ AS JT EH CS JPS KHP PM DS MM. Contributed reagents/materials/analysis tools: PNH HMK BG CDB EH CS JPS KHP PM MM. Wrote the paper: PNH AS CDB PM DS MM.